Reshape Lifesciences Stock Price History
RSLS Stock | USD 0.17 0.01 6.25% |
Below is the normalized historical share price chart for ReShape Lifesciences extending back to October 06, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ReShape Lifesciences stands at 0.17, as last reported on the 23rd of April, with the highest price reaching 0.18 and the lowest price hitting 0.17 during the day.
If you're considering investing in ReShape Stock, it is important to understand the factors that can impact its price. ReShape Lifesciences maintains Sharpe Ratio (i.e., Efficiency) of -0.058, which implies the firm had a -0.058% return per unit of standard deviation over the last 3 months. ReShape Lifesciences exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ReShape Lifesciences' Coefficient Of Variation of (1,172), risk adjusted performance of (0.04), and Market Risk Adjusted Performance of (0.43) to confirm the risk estimate we provide.
Common Stock Shares Outstanding is likely to gain to about 6.3 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 6.3 M in 2024. . At this time, ReShape Lifesciences' Price To Sales Ratio is comparatively stable compared to the past year. Price Sales Ratio is likely to gain to 0.34 in 2024, whereas Price Earnings Ratio is likely to drop (0.14) in 2024. ReShape Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 15th of November 2007 | 200 Day MA 0.4949 | 50 Day MA 0.1698 | Beta 1.296 |
ReShape |
Sharpe Ratio = -0.058
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | RSLS |
Estimated Market Risk
4.29 actual daily | 37 63% of assets are more volatile |
Expected Return
-0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ReShape Lifesciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ReShape Lifesciences by adding ReShape Lifesciences to a well-diversified portfolio.
Price Book 0.5798 | Enterprise Value Ebitda 0.023 | Price Sales 0.4452 | Shares Float 20.8 M | Wall Street Target Price 1 |
ReShape Lifesciences Stock Price History Chart
There are several ways to analyze ReShape Stock price data. The simplest method is using a basic ReShape candlestick price chart, which shows ReShape Lifesciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | January 26, 2024 | 0.21 |
Lowest Price | February 23, 2024 | 0.15 |
ReShape Lifesciences April 23, 2024 Stock Price Synopsis
Various analyses of ReShape Lifesciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ReShape Stock. It can be used to describe the percentage change in the price of ReShape Lifesciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ReShape Stock.ReShape Lifesciences Price Daily Balance Of Power | 1.00 | |
ReShape Lifesciences Accumulation Distribution | 5,766 | |
ReShape Lifesciences Price Rate Of Daily Change | 1.06 |
ReShape Lifesciences April 23, 2024 Stock Price Analysis
ReShape Stock Price History Data
The price series of ReShape Lifesciences for the period between Wed, Jan 24, 2024 and Tue, Apr 23, 2024 has a statistical range of 0.09 with a coefficient of variation of 11.98. The price distribution for the period has arithmetic mean of 0.18. The median price for the last 90 days is 0.17. The company completed stock split (1:50) on 23rd of December 2022. ReShape Lifesciences had dividends distributed to its stock-holders on 2019-07-25.Open | High | Low | Close | Volume | ||
04/22/2024 | 0.17 | 0.18 | 0.17 | 0.17 | 103,794 | |
04/19/2024 | 0.17 | 0.18 | 0.17 | 0.17 | 79,632 | |
04/18/2024 | 0.17 | 0.18 | 0.16 | 0.17 | 431,781 | |
04/17/2024 | 0.17 | 0.17 | 0.16 | 0.16 | 272,954 | |
04/16/2024 | 0.16 | 0.17 | 0.16 | 0.16 | 150,245 | |
04/15/2024 | 0.17 | 0.17 | 0.16 | 0.16 | 172,425 | |
04/12/2024 | 0.16 | 0.17 | 0.16 | 0.16 | 199,442 | |
04/11/2024 | 0.17 | 0.17 | 0.16 | 0.16 | 144,257 | |
04/10/2024 | 0.18 | 0.18 | 0.16 | 0.17 | 228,448 | |
04/09/2024 | 0.17 | 0.18 | 0.16 | 0.17 | 174,036 | |
04/08/2024 | 0.17 | 0.17 | 0.16 | 0.17 | 123,188 | |
04/05/2024 | 0.17 | 0.17 | 0.16 | 0.17 | 405,274 | |
04/04/2024 | 0.17 | 0.18 | 0.17 | 0.17 | 134,121 | |
04/03/2024 | 0.16 | 0.21 | 0.16 | 0.18 | 1,873,869 | |
04/02/2024 | 0.17 | 0.18 | 0.17 | 0.17 | 221,734 | |
04/01/2024 | 0.16 | 0.18 | 0.16 | 0.16 | 660,044 | |
03/28/2024 | 0.19 | 0.20 | 0.18 | 0.18 | 756,830 | |
03/27/2024 | 0.19 | 0.19 | 0.18 | 0.18 | 149,312 | |
03/26/2024 | 0.18 | 0.19 | 0.18 | 0.18 | 298,017 | |
03/25/2024 | 0.19 | 0.19 | 0.19 | 0.19 | 470,352 | |
03/22/2024 | 0.17 | 0.19 | 0.17 | 0.19 | 999,886 | |
03/21/2024 | 0.17 | 0.19 | 0.17 | 0.18 | 656,117 | |
03/20/2024 | 0.16 | 0.17 | 0.16 | 0.17 | 355,820 | |
03/19/2024 | 0.16 | 0.17 | 0.16 | 0.16 | 185,050 | |
03/18/2024 | 0.17 | 0.17 | 0.16 | 0.16 | 219,459 | |
03/15/2024 | 0.17 | 0.17 | 0.16 | 0.16 | 234,893 | |
03/14/2024 | 0.17 | 0.18 | 0.16 | 0.17 | 618,905 | |
03/13/2024 | 0.17 | 0.18 | 0.17 | 0.17 | 285,995 | |
03/12/2024 | 0.18 | 0.18 | 0.16 | 0.17 | 598,720 | |
03/11/2024 | 0.17 | 0.19 | 0.17 | 0.18 | 607,434 | |
03/08/2024 | 0.17 | 0.18 | 0.16 | 0.17 | 142,222 | |
03/07/2024 | 0.16 | 0.19 | 0.15 | 0.17 | 1,560,271 | |
03/06/2024 | 0.16 | 0.16 | 0.15 | 0.16 | 306,627 | |
03/05/2024 | 0.17 | 0.17 | 0.15 | 0.15 | 507,127 | |
03/04/2024 | 0.16 | 0.17 | 0.16 | 0.16 | 722,364 | |
03/01/2024 | 0.17 | 0.17 | 0.16 | 0.17 | 162,814 | |
02/29/2024 | 0.18 | 0.18 | 0.16 | 0.17 | 508,782 | |
02/28/2024 | 0.17 | 0.18 | 0.16 | 0.17 | 1,258,356 | |
02/27/2024 | 0.16 | 0.16 | 0.14 | 0.16 | 761,706 | |
02/26/2024 | 0.15 | 0.15 | 0.15 | 0.15 | 348,954 | |
02/23/2024 | 0.16 | 0.16 | 0.15 | 0.15 | 467,037 | |
02/22/2024 | 0.17 | 0.17 | 0.15 | 0.16 | 1,356,898 | |
02/21/2024 | 0.16 | 0.17 | 0.16 | 0.17 | 301,685 | |
02/20/2024 | 0.18 | 0.22 | 0.16 | 0.17 | 2,365,219 | |
02/16/2024 | 0.17 | 0.18 | 0.17 | 0.17 | 178,413 | |
02/15/2024 | 0.15 | 0.18 | 0.15 | 0.17 | 828,610 | |
02/14/2024 | 0.16 | 0.17 | 0.14 | 0.16 | 1,332,584 | |
02/13/2024 | 0.19 | 0.19 | 0.16 | 0.17 | 860,527 | |
02/12/2024 | 0.19 | 0.20 | 0.18 | 0.18 | 688,809 | |
02/09/2024 | 0.20 | 0.20 | 0.18 | 0.19 | 654,057 | |
02/08/2024 | 0.20 | 0.20 | 0.19 | 0.20 | 278,489 | |
02/07/2024 | 0.20 | 0.20 | 0.19 | 0.20 | 277,716 | |
02/06/2024 | 0.19 | 0.20 | 0.19 | 0.19 | 510,332 | |
02/05/2024 | 0.20 | 0.21 | 0.20 | 0.20 | 378,872 | |
02/02/2024 | 0.20 | 0.21 | 0.19 | 0.20 | 446,948 | |
02/01/2024 | 0.21 | 0.21 | 0.20 | 0.21 | 338,311 | |
01/31/2024 | 0.20 | 0.21 | 0.20 | 0.21 | 367,101 | |
01/30/2024 | 0.21 | 0.22 | 0.21 | 0.21 | 295,958 | |
01/29/2024 | 0.21 | 0.22 | 0.20 | 0.21 | 340,539 | |
01/26/2024 | 0.20 | 0.21 | 0.20 | 0.21 | 419,651 | |
01/25/2024 | 0.21 | 0.21 | 0.20 | 0.20 | 853,376 |
About ReShape Lifesciences Stock history
ReShape Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ReShape is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ReShape Lifesciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ReShape Lifesciences stock prices may prove useful in developing a viable investing in ReShape Lifesciences
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 6 M | 6.3 M | |
Net Loss | -41.6 M | -43.7 M |
ReShape Lifesciences Stock Technical Analysis
ReShape Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
All Next | Launch Module |
ReShape Lifesciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ReShape Lifesciences' price direction in advance. Along with the technical and fundamental analysis of ReShape Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ReShape to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.44) | |||
Total Risk Alpha | (0.90) | |||
Treynor Ratio | (0.44) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ReShape Lifesciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy ReShape Stock please use our How to Invest in ReShape Lifesciences guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for ReShape Stock analysis
When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is ReShape Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReShape Lifesciences. If investors know ReShape will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReShape Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.91) | Revenue Per Share 1.457 | Quarterly Revenue Growth (0.36) | Return On Assets (0.84) | Return On Equity (2.21) |
The market value of ReShape Lifesciences is measured differently than its book value, which is the value of ReShape that is recorded on the company's balance sheet. Investors also form their own opinion of ReShape Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is ReShape Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReShape Lifesciences' market value can be influenced by many factors that don't directly affect ReShape Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReShape Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ReShape Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReShape Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.